肥厚型心肌病——当前挑战与未来展望
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives.
作者信息
Monda Emanuele, Limongelli Giuseppe, Pelliccia Francesco
机构信息
Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.
Department of Cardiovascular Sciences, Sapienza University, 00185 Rome, Italy.
出版信息
J Clin Med. 2023 Sep 21;12(18):6093. doi: 10.3390/jcm12186093.
Abstract
Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by left ventricular (LV) hypertrophy, which cannot be entirely attributed to loading conditions such as valve or congenital heart disease or hypertension [...].
摘要
肥厚型心肌病（HCM）是一种以左心室（LV）肥厚为特征的心肌疾病，其不能完全归因于诸如瓣膜病、先天性心脏病或高血压等负荷情况[……]
相似文献
1
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives.
J Clin Med. 2023 Sep 21;12(18):6093. doi: 10.3390/jcm12186093.
2
3
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.
4
Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
Eur Radiol. 2017 Mar;27(3):1125-1135. doi: 10.1007/s00330-016-4468-2. Epub 2016 Jul 1.
5
Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
Indian Heart J. 2018 Jan-Feb;70(1):75-81. doi: 10.1016/j.ihj.2016.12.021. Epub 2017 Jan 6.
6
Revelation of an obstructive hypertrophic cardiomyopathy in an elderly patient.
Int J Cardiol. 2010 Nov 19;145(2):e41-e43. doi: 10.1016/j.ijcard.2008.12.136. Epub 2009 Jan 31.
7
Strain analysis during exercise in patients with left ventricular hypertrophy: impact of etiology.
J Am Soc Echocardiogr. 2013 Oct;26(10):1163-1169. doi: 10.1016/j.echo.2013.06.002. Epub 2013 Jul 13.
8
Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
Cardiovasc Pathol. 2018 Mar-Apr;33:32-38. doi: 10.1016/j.carpath.2017.12.002. Epub 2018 Jan 3.
9
Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.
Heart Vessels. 2017 Feb;32(2):166-174. doi: 10.1007/s00380-016-0844-8. Epub 2016 May 3.
10
Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
Eur Radiol. 2011 Jul;21(7):1383-9. doi: 10.1007/s00330-011-2065-y. Epub 2011 Jan 28.
引用本文的文献
1
Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy.
Egypt Heart J. 2025 Jun 13;77(1):61. doi: 10.1186/s43044-025-00652-0.
2
A Systematic Review and Meta-analysis of Efficacy and Safety of Mavacamten for the Treatment of Hypertrophic Cardiomyopathy.
Rev Cardiovasc Med. 2024 Oct 23;25(10):375. doi: 10.31083/j.rcm2510375. eCollection 2024 Oct.
3
Myosin-Catalyzed ATP Hydrolysis in the Presence of Disease-Causing Mutations: Mavacamten as a Way to Repair Mechanism.
J Phys Chem B. 2024 May 16;128(19):4716-4727. doi: 10.1021/acs.jpcb.4c01601. Epub 2024 May 6.
本文引用的文献
1
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives.
J Clin Med. 2023 Sep 1;12(17):5710. doi: 10.3390/jcm12175710.
2
2023 ESC Guidelines for the management of cardiomyopathies.
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
3
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine.
Circ Heart Fail. 2023 Aug;16(8):e010687. doi: 10.1161/CIRCHEARTFAILURE.123.010687. Epub 2023 Jul 21.
4
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy.
J Clin Med. 2023 May 10;12(10):3397. doi: 10.3390/jcm12103397.
5
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines.
Circ Genom Precis Med. 2023 Aug;16(4):350-358. doi: 10.1161/CIRCGEN.122.003861. Epub 2023 May 18.
6
Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal Hypertrophy.
J Clin Med. 2023 Apr 21;12(8):3024. doi: 10.3390/jcm12083024.
7
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective.
J Clin Med. 2023 Apr 11;12(8):2810. doi: 10.3390/jcm12082810.
8
Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice.
J Clin Med. 2023 Apr 9;12(8):2788. doi: 10.3390/jcm12082788.
9
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy.
J Clin Med. 2023 Apr 6;12(7):2725. doi: 10.3390/jcm12072725.
10
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions.
J Clin Med. 2023 Mar 24;12(7):2489. doi: 10.3390/jcm12072489.
Zotero 插件